SEC Form 4 · accession 0001127602-17-032686
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & CEO · Director
Period of report
Nov 16, 2017
Accepted (ET)
Nov 17, 2017 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 16, 2017 | M | 1,261 | $30.75 | A | 1,401 | D | |
| Common StockF2 | Nov 16, 2017 | M | 915 | $30.75 | A | 681,630 | I | By Trusts |
| Common Stock | Nov 16, 2017 | M | 5,800 | $53.42 | A | 7,201 | D | |
| Common StockF3 | Nov 16, 2017 | S | 5,700 | $121.16 | D | 1,501 | D | |
| Common StockF4 | Nov 16, 2017 | S | 200 | $119.025 | D | 1,301 | D | |
| Common StockF5 | Nov 16, 2017 | S | 400 | $120.3325 | D | 901 | D | |
| Common StockF6 | Nov 16, 2017 | S | 661 | $121.7411 | D | 240 | D | |
| Common Stock | Nov 16, 2017 | S | 100 | $121.835 | D | 140 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $30.75 | Nov 16, 2017 | M | 1,261 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 1,261 | 5,269 | D |
| Stock OptionsF2 | $30.75 | Nov 16, 2017 | M | 915 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 915 | 4,354 | D |
| Common Stock (Derivative) | $53.42 | Nov 16, 2017 | M | 5,800 | D | Dec 31, 2012 | Dec 31, 2022 | Common Stock | 5,800 | 55,488 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. The transaction was structured as a broker-assisted cashless exercise, such that the number of shares sold was limited to a sufficient number to cover the exercise price of the options and anticipated taxes. The remaining shares are held by a trust beneficially owned by the reporting person.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F3This transaction was executed in multiple trades at prices ranging from $120.70 to $121.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $119.00 to $119.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $120.09 to $120.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $121.14 to $122.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.